141 related articles for article (PubMed ID: 37466473)
1. Neuronal Ptpn1 and Socs3 deletion improves metabolism but not anovulation in a mouse polycystic ovary syndrome model.
Kerbus RI; Inglis MA; Anderson GM
J Endocrinol; 2023 Sep; 259(1):. PubMed ID: 37466473
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor actions on AgRP neurons are not a major cause of reproductive and metabolic impairments in peripubertally androgenized mice.
Kerbus RI; Decourt C; Inglis MA; Campbell RE; Anderson GM
J Neuroendocrinol; 2024 Mar; 36(3):e13370. PubMed ID: 38344844
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
4. Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS.
Sucquart IE; Coyle C; Rodriguez Paris V; Prescott M; Glendining KA; Potapov K; Begg DP; Gilchrist RB; Walters KA; Campbell RE
Endocrinology; 2024 May; 165(7):. PubMed ID: 38788194
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
[TBL] [Abstract][Full Text] [Related]
6. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
[TBL] [Abstract][Full Text] [Related]
8. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
9. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
10. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.
Ressler IB; Grayson BE; Ulrich-Lai YM; Seeley RJ
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1076-84. PubMed ID: 26078189
[TBL] [Abstract][Full Text] [Related]
11. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
12. Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model.
Sun M; Wu Y; Yuan C; Lyu J; Zhao X; Ruan YC; Guo J; Chen H; Huang WQ
Endocrine; 2024 Jan; 83(1):242-250. PubMed ID: 37922092
[TBL] [Abstract][Full Text] [Related]
13. The role of B cells in immune cell activation in polycystic ovary syndrome.
Ascani A; Torstensson S; Risal S; Lu H; Eriksson G; Li C; Teschl S; Menezes J; Sandor K; Ohlsson C; Svensson CI; Karlsson MCI; Stradner MH; Obermayer-Pietsch B; Stener-Victorin E
Elife; 2023 Jul; 12():. PubMed ID: 37401759
[TBL] [Abstract][Full Text] [Related]
14. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
15. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
16. Androgen Excess Increases Food Intake in a Rat Polycystic Ovary Syndrome Model by Downregulating Hypothalamus Insulin and Leptin Signaling Pathways Preceding Weight Gain.
Liu Y; Xu YC; Cui YG; Jiang SW; Diao FY; Liu JY; Ma X
Neuroendocrinology; 2022; 112(10):966-981. PubMed ID: 34847556
[TBL] [Abstract][Full Text] [Related]
17. Involvement of kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats.
Yuan C; Huang WQ; Guo JH; Liu XY; Yang JZ; Chen JJ; Wu Y; Ruan YC; Liu JY; Cui YG; Diao FY; Chan HC
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166242. PubMed ID: 34389474
[TBL] [Abstract][Full Text] [Related]
18. Deletion of PTP1B From Brain Neurons Partly Protects Mice From Diet-Induced Obesity and Minimally Improves Fertility.
Ancel CM; Evans MC; Kerbus RI; Wallace EG; Anderson GM
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34967909
[TBL] [Abstract][Full Text] [Related]
19. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
